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Abstract
Background: Although monitoring foot skin temperatures has been associated with diabetic foot ulcer recurrence,
no studies have been carried out to test the feasibility among European Caucasians. Moreover, the educational
and/or motivational models that promote cognitive or psychosocial processes in these studies are lacking. Thus, we
conducted a pilot randomized controlled trial to test the feasibility of monitoring foot skin temperatures in
combination with theory-based counselling to standard foot care to reduce diabetic foot ulcer recurrence.
Methods: In a single-blinded nurse-led 1-year controlled trial, conducted at a hospital setting in Norway, 41
patients with diabetic neuropathy and previous foot ulcer were randomized to the intervention (n = 21) or control
groups (n = 20). All participants were instructed in foot care and recording observations daily. Additionally, the
intervention group was taught how to monitor and record skin temperature at baseline, and received counselling
every third month supporting them to use the new treatment. Subjects observing temperature differences >2.0 °C
between corresponding sites on the left and right foot on two consecutive days were asked to contact the study
nurse and reduce physical activity. Fisher exact test was used to evaluate the effect of the intervention on the
proportion of subjects with a foot ulcer. Kaplan-Meier survival analysis was performed to compare the two groups
in regard to the time to development of a foot ulcer.
Results: In the intervention group, 67 % (n = 14/21) monitored and recorded skin temperatures ≥80 % of the time
while 70 % (n = 14/20) of the controls recorded foot inspections. Foot ulcer incidence was 39 % (7/21) vs. 50 %
(10/20) in the intervention and control groups, respectively (ns).
Conclusions: This feasibility study showed that the addition of counselling to promote self-monitoring of skin
temperature to standard care to prevent recurrence of foot ulcer is feasible in patients with diabetes in Norway.
Home skin temperature monitoring was performed as frequently by the intervention group as usual foot
observations in the controls despite the extra effort required. We did not detect a difference in foot ulcer
recurrence between groups, but our study may inform future full scale studies.
Trial registration: Clinicaltrials.gov NCT01269502
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Background
Foot ulcers are a feared complication of diabetes. Rates
of diabetes-related complications have declined substan-
tially in the past two decades, but given the increasing
prevalence of diabetes, foot ulcers may be expected to
increase worldwide [1–3]. After a first foot ulcer, the risk
of recurrence is as high as 30–87 % [4, 5]. One possible
reason for the high recurrence rates is that sensory neur-
opathy reduces warning symptoms of pain and inflam-
mation, the major early signs of skin damage and
ulceration [6, 7]. Thus, eliciting objective signs of early
damage may be useful. Several interventions to reduce
the frequency of diabetic foot ulcers have been tested
[6, 8–10]. Three of these studies were randomized con-
trolled trials testing patient monitoring of foot skin
temperature as a warning signal of an impending ulcer
[6, 9, 10]. These studies found a significant reduction
in new foot ulcers with use of a temperature monitor-
ing device. Although monitoring foot skin temperatures
has been associated with diabetic foot ulcer recurrence, no
studies have been carried out to test the feasibility in
Norway and/or among European Caucasians.
Another important aspect of foot ulcer prevention is
patient education. A systematic review found that most
studies failed to address the educational and/or motiv-
ational models that promote cognitive or psychosocial
processes [8]. Ongoing self-management education and
support are important to prevent diabetes complications
[11], and individuals’ readiness to change behavior may
improve the outcome. An individual’s preparedness can
be divided into a pre-action phase or into an action-
phase according to motivation, and in the Transtheoreti-
cal Model (TTM) this may be classified into five stages:
pre-contemplation, contemplation, preparation, action,
and maintenance [12]. Counselling may be tailored to-
ward the stage of change. Use of this model has shown
positive results in a number of studies that aimed to fa-
cilitate lifestyle and behavior change [13, 14].
Thus, we conducted a pilot randomized controlled
trial to test the feasibility of monitoring foot temperature
in combination with theory-based counselling with the
ultimate aim of preventing recurrent diabetic foot ulcers.
The study was conducted at a diabetes specialty clinic in
a university hospital in Norway.
Methods
The study was a single blind randomized controlled pilot
trial with a 1-year follow-up period. Block randomization
was used to assign each four subjects to blocks with two
in each group. Randomization was stratified for patients
with a history of Charcot foot, who have an extra high
risk of recurrence. All study related procedures includ-
ing randomization were performed at the Diabetes
Clinic, Oslo University Hospital.
The study was reviewed by the Regional Committee
for Medical and Health Research Ethics South East
(2009/1129). The participants were guaranteed full con-
fidentiality and each participant gave written informed
consent.
Participants were recruited from six diabetes specialty
outpatient clinics and one chiropodist in the Oslo area.
Inclusion criteria were a diagnosis of type 1 or type 2
diabetes, age 18–80 years, and belonging to group 3 of
the Diabetes Foot Risk classification system (previous
history of foot ulcer and peripheral neuropathy) [15].
Study participants had to be capable of providing in-
formed consent and completing a written questionnaire.
Study participants also had to be willing to measure foot
skin temperature if assigned to the intervention group.
Exclusion criteria included open wounds, active Charcot
disease, active osteomyelitis, or ischemia (not palpable
pulses or ankle/arm index <0.7). Of 110 patients
screened, 41 patients fulfilled the study criteria, provided
consent and were randomly assigned to the intervention
(n = 21) or control group (n = 20) (Fig. 1). All patients
were Caucasian.
The control group was instructed to inspect their feet
under, below and between the toes, and record their ob-
servations in a log book daily. They were instructed to
contact the study nurse if changes in their feet including
a new ulcer were observed. They were also advised to al-
ways wear their customized footwear. For general med-
ical and diabetes care, they consulted their usual general
practitioners.
In addition to the same standard care as the control
group, the intervention group was trained to use a digital
infrared thermometer (Temp Touch; Xilas Medical, San
Antonio, TX) to monitor foot temperature. The thermom-
eter is a handheld device with an infrared heat sensor.
Study subjects were instructed to record daily physical ac-
tivity using a step-counter (Yamax, Tokyo, Japan) during
the first week of the study.
At the baseline visit, the study nurse explained the
purpose of the thermometer and how to conduct daily
self-monitoring of skin temperatures. Temperature was
to be monitored at the same six points under both feet
and recorded in a log book daily. If subjects observed a
difference in skin temperature of >2.0 ° C (2.2 ° C = 4 ° F)
on the same spot in the sole of the foot compared to the
same spot on the opposite foot on two consecutive days,
they were advised to contact the study nurse and to re-
duce physical activity by one-half until the temperature
difference normalized (to <2.0 ° C).
At three-month visits, the study nurse assessed each
subject’s readiness to record skin temperatures according
to TTM stages, followed by tailored stage-based counsel-
ling. The five stages were modified as follows: 1) “I am not
using the thermometer, and do not intend to use it”, 2) “I
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am thinking of using it, but not in the very near future”, 3)
“I will start to use it now”, 4) “I have started to use it, but
not regularly (<80 % of the prescribed time)”, 5) “I am
using it regularly (≥80 % of the prescribed time)".
At baseline and at the end of the study, participants com-
pleted questionnaires that included socio-demographic
variables (age, gender, living conditions, education and em-
ployment status), lifestyle (smoking habits), diabetes-related
variables (diabetes type and duration, co-morbidities, his-
tory of foot ulcers, Charcot foot and any history of lower
limb amputation) and patient related outcomes. At the end
of the study the participants additionally completed a ques-
tionnaire about how often they used customized footwear.
Clinical examinations were performed at baseline and
at study-end. The study nurse measured waist circum-
ference, body weight and height (baseline visit only) to
calculate body mass index (BMI), and conducted an ex-
tensive foot examination including assessment of pedal
pulses and ankle-arm index, bone, trophic changes in
the skin and nails of the feet, and sensory monofilament
and vibration tests. The monofilament test results were
categorized as reduced (7 out of 8 or less) or absent sen-
sation. The vibration perception threshold was catego-
rized as able to sense the vibration or unable to sense
the vibration. An orthopedic surgeon (KH) and an endo-
crinologist (BK) conducted clinical examinations of each
participant at baseline and study end. Glycemic control
was measured by HbA1c [16]. Nephropathy was defined
as urinary albumin/creatinine ratio (ACR) ≥3.0 [17, 18].
In the intervention group adherence to skin temperature
monitoring was recorded as the percentage of days with
foot temperature measurements recorded in the daily log
in the course of the study. In the control group the per-
centage of days with a check indicating foot inspection
was recorded in the daily log in the course of the study.
Foot ulcer occurrence was defined as an end point in the
study and was classified according to Wagner foot classifi-
cation system.
For the purpose of analyses, monitoring of skin
temperature was divided into categories of <80 % or ≥ 80 %
of prescribed. Independent-sample t- tests were used to
evaluate between group comparisons on continuous vari-
ables (age, BMI, waist circumstance, HbA1c, duration of
diabetes and ankle-brachial index). Fisher exact test was
used to evaluate the effect of the intervention on the pro-
portion of subjects with a foot ulcer. Kaplan-Meier survival
analysis was performed to compare the two groups in re-
gard to the time to development of a foot ulcer. Differences
between survival curves in the two groups were tested with
the logrank test. Statistical analyses were undertaken using
SPSS (PASW Statistics for Windows, Version 18.0. Chicago:
SPSS Inc.). Statistical significance was assessed with two-
sided p < 0.05. All analyses were by intention to treat.
Results
There were no significant differences in demographics
characteristics between the intervention and control
groups at baseline. Nephropathy and systemic vascular
Fig. 1 Study enrolment
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risk factor levels above the recommended limits were
more prevalent in the intervention than in the control
group (Table 1). Only one subject in the study popula-
tion reached recommended targets for all levels.
In the intervention group, 67 % (14/21) recorded foot
observations and skin temperatures ≥80 % of the time. In
the control group, 70 % (14/20) recorded foot observa-
tions ≥80 % of the time. During the 1-year follow-up, the
incidence of foot ulcers in the intervention and control
group was 39 % (n = 7/21) and 50 % (n = 10/20) respect-
ively (p = 0.532) (Table 2). Kaplan-Meier survival curves
for the intervention and control group did not differ sig-
nificantly (p = 0.407, chi-squared at 0.687) (Fig. 2).
In the intervention group there was no association be-
tween temperature monitoring ≥80 % compared to mon-
itoring <80 % of the time to foot ulcer occurrence. In
the intervention group 8 out of 21 experienced an in-
creased skin temperature one or more times during the
study. Fifty percent (4/8) of the patients from the inter-
vention group and 33 % (4/12) of the patients from the
control group contacted the study nurse, due to in-
creased skin temperature and observed foot changes
Table 1 Description of the study population
Characteristics Control
group
Intervention
group
n = 20a n = 21a
Sociodemographic characteristics
Age (years) 59,4 (SD
13.0)
57,1 (SD 10, 2)
Male sex (%) 75 86
Living alone (%) 40 33
Education (>12 years) (%) 40 33
Working (full/part time) 45 52
Lifestyle characteristics
BMI (kg/m2) 31.1 (SD 6.4) 31.4 (SD 4.8)
Waist circumference (cm) 110.9 (SD
13.7)
114.9 (SD 13.1)
Current smokers (%) 30 19
Subgroups of diabetes
Type 1 (%) 30 29
Type 2 (%) 70 71
Diabetes-specific variables
HbA1 (mmol/mol) 63 (SD 19) 67 (SD 16)
HbA1c (% units) 7.9 (SD 1.7) 8.3 (SD 1.5)
Insulin use (%) 55 71
Urinary albumin/creatinin ratiob 20* 65 *
Nephropathy (%) 25 48
Duration of diabetes (years) (median) 19.5 17.0
Vascular surgery/ PTA/blocking (%) 15 33
Retinopathy (%) 47 40
Foot surgery (%) 55 53
Charcot foot (%) 20 14
Multiple ulcer history (%) 85 65
A hx of previous toe amputation (%) 40 33
A hx of previous multiple ulcers (%) 85 62
Time since last healed ulcer
<3 months (%) 40 52
3–6 months (%) 35 29
6–12 months (%) 15 9.5
>12 months (%) 10 9.5
Lower extremity examination
Neuropathy evaluation
Semmes-Weinstein 10-g
monofilament right (n)c
15/5 13/8
Semmes-Weinstein 10-g
monofilament left (n)c
18/2 12/9
Vibration perception threshold
right (n)d
7/13 7/14
Vibration perception threshold
left (n)d
9/11 9/12
Table 1 Description of the study population (Continued)
Foot deformity
Hallux valgus (n) 15 12
Claw toe (n) 26 20
Cavus (n) 10 19
Charcot (n) 4 5
Vascular examination
Ankle-brachial index right 1.2 (SD 0.22) 1.2 (SD 0.25)
Ankle-brachial index left 1.2 (SD 0.25) 1.1 (SD 0.12)
Footwear compliance
Time prescribed shoes were worn
(hours)
<4 (%) 10 16
4–8 (%) 25 28
>8–12 (%) 30 28
>12 (%) 35 28
The use of prescribed shoes
Outdoor (%) 30 33
Indoor (%) 5 0
Both in- and outdoor (%) 60 61
Not used (%) 5 5.5
Risk factors (n)e 5/6/13/1 16/12/18/16
Data are means (SD) or %. aSample sizes vary somewhat depending on the
actual completion of the different tests and questionnaires. bPercentage with
ACR >3. cThe results of monofilament test are divided into two categories:
reduced sensation (7 out of 8 or less) or absent sensation. dThe vibration
perception threshold was also divided into two categories: able to sense the
vibration or unable to sense the vibration. eRisk factors: HbA1c >7 %/LDL >2,
5/BP >130/80/ACR > 3. *Significant difference p < 0,01
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respectively, none of these developed a foot ulcer
(Table 2).
Of the total sample, 24 % (n = 5/21) in the intervention
group and 35 % (n = 7/20) in the control group used
customized footwear >12 h a day (p = 0,858). During the
study, there were no major changes in the feet of the
participants until they had a recurrent foot ulcer (which
was the predefined study endpoint) or they stayed in the
study until the end-of-study visit at 1 year. In partici-
pants who contacted the study nurse due to worries
about their feet, there were no major pathologies.
Discussion
This pilot study is, to our knowledge, the first trial re-
ported in a European setting using a skin temperature
device and TTM model as a tool for health care
personnel to prevent recurrence of diabetes related foot
ulcers. Although we did not detect a difference in foot
ulcer recurrence between groups, the study showed that
the intervention is feasible in patients with diabetes and
may inform future, adequately powered studies.
Intervention group patients in our study had a very
high level of adherence with foot temperature recording.
There was no difference between the intervention and
control group regarding the frequency of contact with
the study nurse. This is in contrast to results from the
study performed by Lavery et al. [6] which showed that
among patients in the intervention group who developed
foot ulcers, 80 % did not comply with temperature as-
sessment, and there were fewer study nurse contacts.
The high level of adherence in the present study could
be related to participants having to be initially motivated
to perform temperature assessment and thus, there
might be a selection bias. On the other hand, partici-
pants in both the intervention and control group identi-
fying concerns with their feet with the same frequency
might contribute to the lack of difference between the
groups. The study nurse was easily available at day time.
Future studies may need to emphasize the importance of
contact with health personnel when temperature rises
are noted.
The study by Lavery et al. [6] found an incidence of
recurrent foot ulcer of only 8.5 % in the enhanced ther-
apy group (temperature monitoring, taught by videotape
and checked by study nurse), over a period of 15 months.
We found higher recurrence rate of foot ulcers in the
intervention group (39 %). One explanation of the dif-
ference might be that we included patients who had
high levels of vascular risk factors with levels of HbA1c,
Table 2 Clinical outcomes and voluntary withdrawals
Control
group
Intervention
group
(n = 20) (n = 21)
Patients who contacted study nurse after
self- examination
Worried 4 4
Ulcer 8 6
Foot ulceration 10 7
Voluntary withdrawal from the study 0 3a
aDropout (n = 1) and illness (n = 2)
Fig. 2 Kaplan-Meier survival curves comparing the time to develop a foot ulcer by treatment group. P = 0.407(Log Rank test)
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LDL-cholesterol, blood pressure and urine albumin/
creatinin ratio above recommended treatment targets.
Significantly more patients in the intervention group
had increased urinary albumin excretion (Table 1). Par-
ticipants in our study could thus be more at risk for re-
currence of foot ulcers [15]. Our findings underline the
importance of starting monitoring foot skin tempera-
tures of those at risk for foot ulcers at an early stage.
The use of customized footwear was substantially below
recommendations in both groups. Footwear cannot be ef-
fective if it is not worn, and adherence is known to be low
in diabetic patients [19]. A Randomized Controlled Trial
among patients with foot pathology shows that the design
and user friendliness of footwear is an important factor
for compliance [20]. In self-management and support to
patients with diabetes and high-risk foot conditions, more
emphasize should be on the use of customized footwear
indoors.
This study has limitations. The current study is under-
powered to show differences between study groups. The
sample size is too small to detect differences in moder-
ate effect sizes between the intervention and the control
group. Based on the pilot study results, 124 participants
per group would be needed to have 80 % power to de-
tect a difference at 5 % significance level. However, the
aim was to test the feasibility of introducing temperature
measurement in secondary prevention of diabetic foot
ulcers in specialist centre in Norway. Another limitation
in our study was that we implemented two interven-
tions, the use of a thermometer for monitoring together
with a theory-based counseling by a specialist diabetes
nurse. This makes it difficult to separate the effect of
each component and limits direct comparisons with pre-
vious studies. In our study the study nurse met the pa-
tients in the intervention group every third month.
Effective communication with the patients is the corner-
stone in a nurse-patient relationship, and vital to the
providing of good care to the patient in hospital [21].
However, it takes time to build trust and motivation in
order to change patient behavior and it is timely to raise
the question if more frequent contact, perhaps monthly,
or contact such as via telephone or email or Skype,
could have strengthened the intervention. In spite of
these limitations this feasibility study should provide
knowledge to estimate important parameters that are
needed to design the main study, (willingness of patients
to be randomized, inclusion criteria, number of people
eligible, follow-up rates, response rates and adherence/
compliance rates) [22].
Conclusions
With the aging of our population, the increased incidence
and prevalence of diabetes, and the high personal and eco-
nomic costs of diabetic foot ulcers, further attempts to
improve clinical outcomes are merited. This feasibility
study showed that the addition of counselling to promote
self-monitoring of skin temperature to standard care to
prevent recurrence of foot ulcer is feasible in patients with
diabetes in Norway. Although we did not find any signifi-
cant differences in foot ulcer development in the two
groups, the knowledge gained in this study about the use
of self-monitoring devices in combination with the use of
theory-based counseling for patients with diabetes at risk
for foot ulcers, may inform future full scale interventions
to improve behavior change and foot ulcer recurrence.
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